Crinetics | News & Events

PRESS RELEASES

Press Release | May 10, 2023

Crinetics Announces May 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Press Release | May 4, 2023

Crinetics Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

Press Release | April 9, 2023

Crinetics Announces April 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Press Release | March 10, 2023

Crinetics Announces March 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Press Release | February 28, 2023

Crinetics Reports Fourth Quarter and Full Year 2022 Financial Results

Press Release | February 10, 2023

Crinetics Announces February 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Press Release | February 10, 2023

Crinetics Pharmaceuticals to Participate in the SVB Securities Global Biopharma Conference

Press Release | January 10, 2023

Crinetics Announces January 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Press Release | January 9, 2023

Crinetics Pharmaceuticals to Present Corporate and Clinical Update at 41st Annual J.P. Morgan Healthcare Conference

Press Release | December 12, 2022

Crinetics Announces December 2022 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11 / 24

Transforming Endocrine Disease Treatment

Be the first to know about the advances we're making in endocrine-rooted care.

Email Signup